Medication and mental health

ADHD Treatment Options: Medications, Therapy, and What Works Best

ADHD treatment works best with the right plan.

A man with a beard wearing a navy blue cap, white t-shirt, and jeans stands against a plain light background, shrugging with both hands raised and an uncertain expression—like someone navigating ADHD treatment Ontario options.

Understanding ADHD medication

Learn why stimulants lead, non-stimulants are catching up, and therapy can supercharge results.

ADHD Medication FAQ's

Stimulant medications (lisdexamfetamine and methylphenidate) as well as selective norepinephrine reuptake inhibitors (SNRI) (atomoxetine) were the only treatments that consistently reduced core ADHD symptoms, both from the perspective of patients and clinicians.

 

Belo you can find a helpful Canadian medication chart, as well as current formulary coverage for these medicines across Canada. 

Stimulant medications have shown to offer symptomatic improvement in areas like:

  • The ability to have sustained attention and on-task behaviours, resulting in improved academic performance,
  • Enhanced daily functioning, both at home, on the job,
  • Enhanced relational functioning,
  • Decreased risk of later substance use disorders when initiated in childhood,
  • Decreased risk of motor vehicle collisions.

Long-acting stimulants (instead of short-acting) have been shown to less prone to abuse or diversion compared to their short-acting counterparts.

There are two main categories of psychostimulant medication: Amphetamines and Methylphenidate.

Stimulant medicines achieve their beneficial effects by increasing the levels or availability, of neurotransmitters dopamine, serotonin, and norepinephrine in the brain.  

  • Dopamine, one of the most important neurotransmitters, has been directly linked to concentration, attention, and more recently show to be directly related to motivation and the willingness to take on difficult tasks. 
  • Norepinephrine plays an important role in daytime alertness. 
  • Glutamate Some stimulant drugs also increase the level of glutamate, a neurotransmitter associated with behavioural control and inhibition. 

When you start a trial of stimulant medication, it’s important to appreciate what outcomes you should be  looking for (see above!).

That is, you must track how symptoms such as impulsiveness, concentration, motivation, emotional dysregulation are affected in your daily life.

This helps you collaborate with your physician, nurse practitioner or ADHD therapist, to plan your treatment, and tailor the medical treatment to your brain.

What about cannabis?

Many people ask about the effects of cannabis on the ADHD brain, both in terms of treatment, and also because of the high rate of co-use in terms of cannabis substance use disorder. 

CADDRA has published a position statement on the use of Cannabis in ADHD, and can be reviewed here. 

Tracking Progress

How do we know if it’s all working? How do you track progress?

One of the biggest risk of harm in an ADHD patient’s experience in therapy is when a medication target is treated the same as a psychological target.

Tracking your unique symptoms and sharing your observations with your therapist is the only way to tell where ADHD ends (the invisible brain driven stuff), and you (the conscious choice maker) begin. 

Download, Track and Share with your Therapist

Get our free
ADHD Symptom Tracker

New Research Highlights

Factors Associated With Medication Adherence Among Patients With Attention-Deficit/Hyperactivity Disorder (ADHD). Journal of attention disorders, 29(12), 1039–1053. https://doi.org/10.1177/10870547251336852

Hear from the experts!

Listen in to the premiere episode of The Christina Crowe Podcast: making the invisible VISIBLE, featuring Dr. Joan Flood, talking about the nuances of evidenced-based treatment for ADHD brains.

ADHD Patient Associations

For current and evidenced based information about medication, please visit reputable websites like the Canadian ADHD Resource Alliance (CADDRA) or CADDAC. 


  1. CADDRA is an independent, not-for-profit, resource organization for medical, healthcare and research professionals with an interest in the field of ADHD.  
  2. For school or workplace advocacy, free education, workshops for parents and other ADHD related resources, you can also visit the Canadian national patient advocacy association, CADDAC. 

Need help with treatment costs?

A reminder:
If you have coverage for medication through your employer, it’s generally your employer that determines whether or not the plan members have coverage for generic versus brand (not the insurance company).  Even employees from the same company can have varying levels of coverage.
 
  • You can self-advocate through your HR department, patient advocacy organizations, or through the media (patients/HCPs) and ask for exceptional coverage to meet yours or your family needs. 
  • For medications listed on Ontario Drug Benefit (ODB) people under 25 can receive their medication for free under OHIP+ at a pharmacy if they do not have private insurance coverage from parents.
In Canada: 
In the U.S.: 
Get Evaluated by a Nurse Practitioner

Are you a therapist?

In multi-modal care, clarity about treatment is important.

Learn how to effectively integrate multi-modal treatment goals with your clients with ADHD, from an experienced ADHD therapist and clinical supervisor.